KMG FIDUCIARY PARTNERS, LLC: AVUV position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of KMG FIDUCIARY PARTNERS, LLC on AVUV, newest first. How the timeline and the estimate are built.
KMG FIDUCIARY PARTNERS, LLC held 0 AVUV shares at 2026-09-30 per its 13F-HR filed 2026-10-14.
the latest 13F is the newest step
- period ended2026-09-3013F 0 sharesChange vs previous 13F -7,807 shares
13F-HR 0001754960-26-000859 filed by KMG FIDUCIARY PARTNERS, LLC
Accepted , ingestedExited: the 13F for this period no longer lists the position.
- period ended2026-06-3013F 7,807 sharesChange vs previous 13F +126 shares
0.09% of the 13F portfolio, value $974,047.
13F-HR 0001754960-26-000440 filed by KMG FIDUCIARY PARTNERS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 7,681 sharesChange vs previous 13F +106 shares
0.06% of the 13F portfolio, value $848,560.
13F-HR 0001754960-26-000219 filed by KMG FIDUCIARY PARTNERS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 7,575 sharesChange vs previous 13F +468 shares
0.05% of the 13F portfolio, value $772,535.
13F-HR 0001754960-26-000056 filed by KMG FIDUCIARY PARTNERS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 7,107 sharesChange vs previous 13F -797 shares
0.05% of the 13F portfolio, value $707,385.
13F-HR 0001754960-25-000651 filed by KMG FIDUCIARY PARTNERS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 7,904 sharesChange vs previous 13F not available
0.05% of the 13F portfolio, value $720,066.
13F-HR 0001754960-25-000344 filed by KMG FIDUCIARY PARTNERS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).